July 1, 2026
1 min read

Lonza expands partnership with US drugmaker, boosts capacity for ADCs

Contract manufacturing powerhouse Lonza is growing in more ways than one. The Swiss company revealed this week that it is expanding its capacity to manufacture antibody-drug conjugates—and that it has increased the scope of its partnership with a large, unnamed U.S. drugmaker.

Leave a Reply

Your email address will not be published.

Previous Story

Can A Popular Muscle Supplement Help Treat Depression? MedNews

Next Story

FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel MedNews

Previous Story

Can A Popular Muscle Supplement Help Treat Depression? MedNews

Next Story

FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel MedNews

Latest from Blog

Go toTop